Kidd血型相关SLC14A1基因在肾透明细胞癌中的表达及临床意义

doi:10.3969/j.issn.1671-2587.2024.01.015

临床输血与检验 ›› 2024, Vol. 26 ›› Issue (1): 92-100.DOI: 10.3969/j.issn.1671-2587.2024.01.015

Kidd血型相关SLC14A1基因在肾透明细胞癌中的表达及临床意义

周仁龙¹, 钟靖², 唐丹丹³

¹深圳市龙华区中心医院输血科 518100;
²邵阳市中心医院输血科 422000;
³深圳市南山区医疗集团总部 518000

收稿日期:2023-11-25 发布日期:2024-03-13
通讯作者: 唐丹丹,主要从事输血与肿瘤的相关基础研究,（E-mail）1024129289@qq.com。
作者简介:周仁龙,主要从事血型与疾病相关的基础研究,（E-mail）942322151@qq.com。

Expression of Kidd Blood Group Related SLC14A1 Gene in Kidney Renal Clear Cell Carcinoma and Its Clinical Significance

ZHOU Renlong¹, ZHONG Jin², TANG Dandan³

¹Department of Blood Transfusion,Shenzhen Longhua District Central Hospital, Shenzhen 518100;
²The Central Hospital of Shaoyang 422000;
³Shenzhen Nanshan District Medical Group Headquarters 518000

Received:2023-11-25 Published:2024-03-13

摘要/Abstract

摘要： 目的探讨Kidd血型溶质载体家族14基因（solute carrier family 14,SLC14A1）在肾透明细胞（kidney renal clear cell carcinoma,KIRC）中的表达及临床意义。方法运用生物信息学分析方法,联合SANGERBOX、GEPIA、UALCAN、STRING等数据库分析和评估SLC14A1在KIRC中的表达和临床预后价值。结果 Kidd血型SLC14A1基因在4种肿瘤中观察到了显著上调（P<0.05）,在22种肿瘤中观察到了显著下调（P<0.05）,其中SLC14A1在KIRC组织中mRNA表达水平显著低于正常组织（1.35±1.69 vs 3.90±2.47,P=4.7e-36）。生存分析表明,SLC14A1表达水平与KIRC总体生存率呈显著正相关（P<0.05）。基于单因素Cox和多因素Cox回归结果分析低表达SLC14A1是KIRC预后危险因素。KEGG富集分析代谢途径通路占主导地位,GO富集分析吞噬体酸化、三价铁运输、转铁蛋白转运占主导地位。结论 Kidd血型SLC14A1基因在多数KIRC中呈现低表达,与KIRC的发生、发展和预后不良相关,有望作为KIRC诊断、预后判断和治疗靶点。

关键词: 肾透明细胞癌, Kidd血型, SLC14A1基因, 生物信息学, 癌症基因组图谱

Abstract: Objective To investigate the expression and clinical significance of Kidd blood group solute carrier family 14 (SLC14A1) gene in kidney clear cell carcinoma (KIRC). Methods Bioinformatics analysis was used to analyze and evaluate the expression and clinical prognostic value of SLC14A1 in KIRC in combination with SANGERBOX, GEPIA, UALCAN, STRING and other databases. Results Kidd blood group SLC14A1 gene was significantly up-regulated in 4 tumors (P<0.05), and significantly down regulated in 22 tumors (P<0.05). The mRNA expression level of SLC14A1 in KIRC tissues was significantly lower than that in normal tissues (tumor1.35±1.69 vs normal 3.90±2.47, P<0.05). Survival analysis showed that the expression level of SLC14A1 was significantly positively correlated with the overall survival rate of KIRC (P<0.05). Based on univariate Cox and multivariate Cox regression analysis, low expression of SLC14A1 was a prognostic risk factor for KIRC. KEGG enrichment analysis dominates in metabolic pathways. GO enrichment analysis dominates in phagosome acidification, trivalent iron transport and transferrin transport. Conclusion The low expression of Kidd blood group SLC14A1 gene in KIRC is associated with the occurrence, development and poor prognosis of KIRC, which is expected to be used as a possible target for KIRC diagnosis, prognosis judgment and treatment.

Key words: Kidney renal clear cell carcinoma, Kidd blood group, SLC14A1 gene, Bioinformatics, TCGA

中图分类号:

R457.1⁺1

周仁龙, 钟靖, 唐丹丹. Kidd血型相关SLC14A1基因在肾透明细胞癌中的表达及临床意义[J]. 临床输血与检验, 2024, 26(1): 92-100.

ZHOU Renlong, ZHONG Jin, TANG Dandan. Expression of Kidd Blood Group Related SLC14A1 Gene in Kidney Renal Clear Cell Carcinoma and Its Clinical Significance[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(1): 92-100.

参考文献

[1] WANG C B,HE Y,ZHENG J,et al.Dissecting order amidst chaos of programmed cell deaths:construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment[J].Front Immunol,2023,14:1130513.
[2] SOBCZUK P,TRZCINSKA-DANIELEWICZ J,KOPERSK
I L,et al.Angiotensin-(1-7) can promote cell migration and tumor growth of clear cell renal cell carcinoma[J].J Physiol Pharmacol,2022,73(6):10.26402/jpp.2022.6.04.
[3] YU Q,FU W H,FU Y T,et al.BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours[J].Mol Cancer,2023,22(1):143.
[4] CHEN X M,LI C Y,ZENG R,et al.Propofol Regulates HIF-1 α Effect of Expression of Targeted SIRT1 Signal pathway on Kidney Renal Clear Cell Carcinoma[J].Cell Mol Biol,2023,69(3):145-149.
[5] WAN X M,ZHANG Y C,TAN C Q,et al.First-line nivolumab plus ipilimumab vs sunitinib for metastatic renal cell carcinoma:a cost-effectiveness analysis[J].JAMA Oncol,2019,5(4):491-496.
[6] LONG Z L,SUN C F,TANG M,et al.Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma[J].Cell Discov,2022,8(1):68.
[7] HUANG R Z,ZHANG C Y,WANG X,et al.Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC[J].Cancer Med,2022,11(21):3993-4004.
[8] 彭璇,付荣.狼疮肾炎肾小球中细胞焦亡的生物信息学分析及验证[J].医学研究杂志,2023,52(5):62-67.
[9] 章昊,梁爽,李乐兵,等.流式细胞术应用于Kidd血型Jka抗原检测的建立[J].中国实验血液学杂志,2022,30(1):250-255.
[10] VORHOLT S M,LENZ V,JUST B,et al.High-throughput next-generation sequencing of the Kidd blood group:unexpected antigen expression properties of four alleles and detection of novel variants[J].Transfus Med Hemother,2022,50(1):51-65.
[11] WAN Z Q,WANG Y L,LI C,et al.SLC14A1 is a new biomarker in renal cancer[J].Clin Transl Oncol,2023,25(8):2607-2623.
[12] YE B,DING K,LI K X,et al.Study on the role of SLC14A1 gene in biochemical recurrence of prostate cancer[J].Sci Rep,2022,12(1):17064.
[13] ZHOU Y F,YUAN Y,ZHANG Q N,et al.Downregulation of SLC14A1 expression indicates poor prognosis and promotes the progression of non-small cell lung cancer[J].Ann Clin Lab Sci,2022,52(5):753-762.
[14] DONG Q Y,ZHANG S H,ZHANG H T,et al.MARCO is a potential prognostic and immunotherapy biomarker[J].Int Immunopharmacol,2023,116:109783.
[15] TANG Z F,LI C W,KANG B X,et al.GEPIA:a web server for cancer and normal gene expression profiling and interactive analyses[J].Nucleic Acids Res,2017,45(W1):W98-W102.
[16] SHI T D,HU Z X,TIAN L,et al.Pan-cancer landscape of CENPO and its underlying mechanism in LUAD[J].Respir Res,2023,24(1):113.
[17] SHEN W T,SONG Z G,ZHONG X,et al.Sangerbox:acomprehensive,interaction-friendly clinical bioinformatics analysis platform[J].iMeta,2022,1(3):e36.
[18] LIU T,YANG K,CHEN J M,et al.Comprehensive pan-cancer analysis of KIF18A as a marker for prognosis and immunity[J].Biomolecules,2023,13(2):326.
[19] TAI P P,WANG Z W,CHEN X Y,et al.Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers[J].Cancer Med,2023,12(10):11941-11959.
[20] SZKLARCZYK D,GABLE A L,NASTOU K C,et al.The STRING database in 2021:customizable protein-protein networks,and functional characterization of user-uploaded gene/measurement sets[J].Nucleic Acids Res,2021,49(D1):D605-D612.
[21] ZHAO Y Q,REDMAN M W,LEBLANC M L.Quantifying treatment effects using the personalized chance of longer survival[J].Stat Med,2019,38(28):5317-5331.
[22] KIM M H,BANERJEE S,ZHAO Y Z,et al.Association networks in a matched case-control design-Co-occurrence patterns of preexisting chronic medical conditions in patients with major depression versus their matched controls[J].J Biomed Inform,2018,87:88-95.
[23] REDCHUK T A,KABERNIUK A A,VERKHUSHA V V.Near-infrared light-controlled systems for gene transcription regulation,protein targeting and spectral multiplexing[J].Nat Protoc,2018,13(5):1121-1136.
[24] LAWICKI S,COVIN R B,POWERS A A.The Kidd (JK) blood group system[J].Transfus Med Rev,2017,31(3):165-172.
[25] HAMILTON J R.Kidd blood group system:a review[J].Immunohematology,2015,31(1):29-35.
[26] 陈智玮,张宁洁,王勇军.多次输血产生抗-Jkb抗体合并抗-cE抗体1例[J].临床输血与检验,2020,22(1):32-36.
[27] 刘邑阳,郝一文.Kidd血型抗体致疑难配血3例[J].临床输血与检验,2018,20(3):319-321.
[28] LISSA D,ISHIGAME T,NORO R,et al.HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients[J].Lung Cancer,2018,122:151-159.

Kidd血型相关SLC14A1基因在肾透明细胞癌中的表达及临床意义

Expression of Kidd Blood Group Related SLC14A1 Gene in Kidney Renal Clear Cell Carcinoma and Its Clinical Significance

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	周仁龙, 黄国清, 李凌波, 唐丹丹. 血型CD59基因在胰腺癌中的表达及临床意义[J]. 临床输血与检验, 2024, 26(1): 101-109.
[2]	郭彬瀚, 叶萍, 陈剑, 凤婧, 江咏梅. 基于生物信息学探究红细胞储存时间对子宫内膜癌的影响[J]. 临床输血与检验, 2023, 25(6): 789-797.
[3]	夏悦昕, 刘志远, 宋文倩, 邵林楠, 梁晓华, 周世航. 先天性纯红细胞再生障碍性贫血氧化应激相关差异表达基因的生物信息学分析[J]. 临床输血与检验, 2023, 25(1): 82-87.
[4]	郑艳, 张茜, 孙菲. 敲低S100A1通过降低WNT/β-catenin信号活性抑制甲状腺癌SW579细胞增殖[J]. 临床输血与检验, 2021, 23(2): 146-152.
[5]	刘邑阳,郝一文. Kidd血型抗体致疑难配血3例[J]. 临床输血与检验, 2018, 20(3): 319-321.